Drugs / SAR445399
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07547436 | Jun 2026 → Oct 2027 expected | bronchiectasis | Sanofi | Recruiting | No outcome recorded |
| Phase 2 | NCT07225569 | Dec 2025 → Sep 2027 expected | hidradenitis suppurativa | Sanofi | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAR445399 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07547436 ↗ |